FI973529L - Askomysiinejä - Google Patents

Askomysiinejä Download PDF

Info

Publication number
FI973529L
FI973529L FI973529A FI973529A FI973529L FI 973529 L FI973529 L FI 973529L FI 973529 A FI973529 A FI 973529A FI 973529 A FI973529 A FI 973529A FI 973529 L FI973529 L FI 973529L
Authority
FI
Finland
Prior art keywords
ascomycins
Prior art date
Application number
FI973529A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973529A0 (fi
FI973529A7 (fi
Inventor
Rene Hersperger
Reto Naef
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9507128.8A external-priority patent/GB9507128D0/en
Priority claimed from GBGB9526049.3A external-priority patent/GB9526049D0/en
Priority claimed from GBGB9526050.1A external-priority patent/GB9526050D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI973529A0 publication Critical patent/FI973529A0/fi
Publication of FI973529A7 publication Critical patent/FI973529A7/fi
Publication of FI973529L publication Critical patent/FI973529L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
FI973529A 1995-04-06 1996-04-04 Askomysiinejä FI973529L (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9507128.8A GB9507128D0 (en) 1995-04-06 1995-04-06 Organic compounds
GBGB9526049.3A GB9526049D0 (en) 1995-12-20 1995-12-20 Organic compounds
GBGB9526050.1A GB9526050D0 (en) 1995-12-20 1995-12-20 Organic compounds
PCT/EP1996/001492 WO1996031514A1 (en) 1995-04-06 1996-04-04 Ascomycins

Publications (3)

Publication Number Publication Date
FI973529A0 FI973529A0 (fi) 1997-08-27
FI973529A7 FI973529A7 (fi) 1997-11-25
FI973529L true FI973529L (fi) 1997-11-25

Family

ID=27267660

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973529A FI973529L (fi) 1995-04-06 1996-04-04 Askomysiinejä

Country Status (21)

Country Link
US (1) US5925649A (cs)
EP (1) EP0819130A1 (cs)
JP (1) JP2000505044A (cs)
KR (1) KR19980703583A (cs)
CN (1) CN1088068C (cs)
AR (1) AR004480A1 (cs)
AU (1) AU703523B2 (cs)
BR (1) BR9604808A (cs)
CA (1) CA2216562A1 (cs)
CO (1) CO4750668A1 (cs)
CZ (1) CZ312397A3 (cs)
FI (1) FI973529L (cs)
HU (1) HUP9801993A3 (cs)
IL (1) IL117815A (cs)
MX (1) MX9707636A (cs)
NO (1) NO309273B1 (cs)
NZ (1) NZ307170A (cs)
PL (1) PL322553A1 (cs)
SK (1) SK133997A3 (cs)
TR (1) TR199700999T1 (cs)
WO (1) WO1996031514A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE269075T1 (de) 1998-03-26 2004-07-15 Fujisawa Pharmaceutical Co Makrolid-formulierung mit verzögerter wirkstoffabgabe
ES2284248T3 (es) * 1998-04-27 2007-11-01 Astellas Pharma Inc. Formulacion farmaceutica en gel que comprende un compuesto triciclico (fk-506/tacrolimus).
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6121257A (en) * 1999-03-31 2000-09-19 Abbott Laboratories Sulfamate containing macrocyclic immunomodulators
CN1190194C (zh) * 1999-04-30 2005-02-23 苏坎波公司 用于治疗干眼的大环内酯化合物的应用
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
AU769315B2 (en) 1999-08-24 2004-01-22 Cellgate, Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
AR033151A1 (es) * 2001-04-12 2003-12-03 Sucampo Pharmaceuticals Inc Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares
US20030119797A1 (en) * 2001-05-09 2003-06-26 Salah-Dine Chibout Methods for selective immunomodulation
TWI324925B (en) * 2001-08-23 2010-05-21 Novartis Ag Ophthalmic composition
US20060035879A1 (en) * 2002-11-15 2006-02-16 Prescott Margaret F Organic Compounds
US20060115522A1 (en) * 2003-02-17 2006-06-01 Cipla Ltd Pharmaceutical composition
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
US7780973B2 (en) * 2003-12-15 2010-08-24 Ethicon Endo-Surgery, Inc. Method and device for minimally invasive implantation of biomaterial
US20050142161A1 (en) * 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
JP2007516951A (ja) * 2003-12-30 2007-06-28 アステラス製薬株式会社 気道閉塞症の治療または予防のためのマクロライドの使用
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
ES2898849T3 (es) 2014-10-28 2022-03-09 Koushi Yamaguchi Medicamento para mejorar el síndrome de hipertensión inducida por el embarazo
CA3108863A1 (en) 2018-08-10 2020-02-13 Koushi Yamaguchi Therapeutic agent for humoral immunity-related diseases in materno-fetal relationship
EP3900729A4 (en) 2018-12-18 2022-09-07 Koushi Yamaguchi MEANS OF IMPROVING INFERTILITY, REPEATED MISSORS AND PREGNANCY CONDITIONS

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244592A (en) * 1962-06-09 1966-04-05 Arai Tadashi Ascomycin and process for its production
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JPS6317884A (ja) * 1986-05-30 1988-01-25 Fujisawa Pharmaceut Co Ltd トリシクロ化合物
JPH01125394A (ja) * 1987-11-10 1989-05-17 Mect Corp シアロシルグリセロリピッド類及びその製造方法
JP2799208B2 (ja) * 1987-12-09 1998-09-17 フアイソンズ・ピーエルシー マクロ環状化合物
EP0487593A1 (en) * 1989-08-18 1992-06-03 FISONS plc Macrocyclic compounds
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
NZ235991A (en) * 1989-11-09 1993-05-26 Sandoz Ltd Macrolide compounds and pharmaceutical compositions thereof
WO1991013899A1 (en) * 1990-03-12 1991-09-19 Fujisawa Pharmaceutical Co., Ltd. Tricyclo compounds
JPH05507915A (ja) * 1990-06-11 1993-11-11 藤沢薬品工業株式会社 特発性血小板減少性紫斑病およびバセドウ病治療薬製造のためのfk506等のマクロライド化合物の用途
MY110418A (en) * 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
ATE150304T1 (de) * 1990-09-04 1997-04-15 Fujisawa Pharmaceutical Co Tricyclische verbindungen enthaltende salben
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
US5252732A (en) * 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
ATE299017T1 (de) * 1994-10-26 2005-07-15 Novartis Pharma Gmbh Arzneimittel

Also Published As

Publication number Publication date
CN1088068C (zh) 2002-07-24
IL117815A (en) 2000-07-16
CZ312397A3 (cs) 1998-01-14
MX9707636A (es) 1998-06-30
EP0819130A1 (en) 1998-01-21
KR19980703583A (ko) 1998-11-05
CN1180359A (zh) 1998-04-29
CA2216562A1 (en) 1996-10-10
FI973529A0 (fi) 1997-08-27
US5925649A (en) 1999-07-20
PL322553A1 (en) 1998-02-02
JP2000505044A (ja) 2000-04-25
HUP9801993A3 (en) 2000-04-28
NO309273B1 (no) 2001-01-08
FI973529A7 (fi) 1997-11-25
NZ307170A (en) 1999-03-29
HUP9801993A2 (hu) 1998-12-28
AR004480A1 (es) 1998-12-16
WO1996031514A1 (en) 1996-10-10
IL117815A0 (en) 1996-08-04
BR9604808A (pt) 1998-06-09
NO974536D0 (no) 1997-10-01
SK133997A3 (en) 1998-05-06
TR199700999T1 (xx) 1998-01-21
NO974536L (no) 1997-10-01
AU703523B2 (en) 1999-03-25
CO4750668A1 (es) 1999-03-31
AU5645396A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
FI973529A7 (fi) Askomysiinejä
ATA135896A (de) Skibob
ATE198470T1 (de) Alkenyl-benzoylguanidine
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
BR9501643A (pt) Helistato
SE9501165D0 (sv) Hållaranordning
BR7501426U (pt) Búlica
BR7501298U (pt) Torre-audio-visual
BR7502853U (pt) Faixa-surf
BR7502714U (pt) Impresscard
BR7502653U (pt) Publi-taxi
BR7502098U (pt) T-compacto
BR7502025U (pt) Kantil
BR7501939U (pt) Caixa-ambalgem
BR7501858U (pt) Tellelight
BR7501836U (pt) Protecheque
BR7501828U (pt) Multicopo
BR7500040U (pt) Raquet mastit
BR7501485U (pt) Fibropiso
BR7501467U (pt) Vassourágua
BR7501437U (pt) Leiteira
BR7500437U (pt) Girolight
BR7501399U (pt) Ciclonavegador
BR7501376U (pt) Massarreal